Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever by E Kiykim et al.
POSTER PRESENTATION Open Access
Screening for inherited metabolic disorders in
patients with Familial Mediterranean Fever
E Kiykim1, AC Aktuglu-Zeybek1, K Barut2, T Zubarioglu1, MS Cansever1, A Aydin1, O Kasapcopur2*
From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
Dresden, Germany. 30 September - 3 October 2015
Introduction
Familial Mediterranean fever (FMF) is an autosomal
recessive auto-inflammatory disease, presenting with
recurrent episodes of fever and polyserositis. Diagnosis
of FMF is may be challenging especially in pediatric
population. Mitochondrial fatty acid oxidation disorders
and porphyrias can present with periodic abdominal and
muscle pain. Incidence of both FMF and inherited meta-
bolic disorders (IMD) are increased in Turkish patients
partially due to high consanguinity rates.
Objectives
The aim of the present study is determine the inherited
metabolic disorders in differential diagnosis of Turkish
pediatric FMF patients.
Methods
174 patients who were diagnosed as FMF enrolled the
study. In all patients, a fasting dry spot blood sample
was taken for acyl-carnitine analyses by tandem mass
spectrometry. Fresh, light-protected spot urine test was
performed for porphobilinogen screening. Second-tier
test with urine organic acid analysis and urine porphyrin
metabolites were performed if pathologic findings were
detected in acyl-carnitine profile or in porphobilinogen
screening, for confirmation. An age matched healthy 50
children served as control group.
Results
Of the 174 patients diagnosed with FMF, none of our
patients was diagnosed with porphyria; two patients
with fatty acid oxidation defect, one with multiple acyl-
CoA dehydrogenase deficiency and one with possible
medium-chain acyl-CoA dehydrogenase deficiency were
detected during the study.
Conclusion
Our data revealed that screening for porphobilinogen
for pediatric FMF patients is unnecessary, but an inves-
tigation of tandem mass based acyl-carnitine analyses
can be helpful for the differential or additional diagnosis
of FMF in developing countries that does not have
nationwide expanded newborn screening programme.
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